Accès gratuit
Numéro |
Med Sci (Paris)
Volume 27, Numéro 6-7, Juin–Juillet 2011
|
|
---|---|---|
Page(s) | 626 - 631 | |
Section | M/S Revues | |
DOI | https://doi.org/10.1051/medsci/2011276015 | |
Publié en ligne | 1 juillet 2011 |
- TakahashiM, RapleyE, BiggsPJ, et al. Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12–q13. Hum Genet 2000 ; 106 : 58-65. [CrossRef] [PubMed] [Google Scholar]
- BignellGR, WarrenW, SealS, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000 ; 25 : 160-165. [CrossRef] [PubMed] [Google Scholar]
- Poblete GutiérrezP, EggermannT, HöllerD, et al. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J Invest Dermatol 2002 ; 119 : 527-531. [CrossRef] [PubMed] [Google Scholar]
- ZhengG, HuL, HuangW, LDCY, et al. CYLD mutation causes multiple familial trichoepithelioma in three Chinese familiesHum Mutat 2004 ; 23 : 400. [CrossRef] [Google Scholar]
- PickartCM, EddinsMJ. Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 2004 ; 1695 : 55-72. [CrossRef] [PubMed] [Google Scholar]
- WingetJM, MayorT. The diversity of ubiquitin recognition : hot spots and varied specificity. Mol Cell 2010 ; 38 : 627-635. [CrossRef] [PubMed] [Google Scholar]
- SteinmetzMO, AkhmanovaA. Capturing protein tails by CAP-Gly domains. Trends Biochem Sci 2008 ; 33 : 535-545. [CrossRef] [PubMed] [Google Scholar]
- TrompoukiE, HatzivassiliouE, TsichritzisT, et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 2003 ; 424 : 793-796. [CrossRef] [PubMed] [Google Scholar]
- KovalenkoA, Chable-BessiaC, CantarellaG, et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 2003 ; 424 : 801-805. [CrossRef] [PubMed] [Google Scholar]
- BrummelkampTR, NijmanSM, DiracAM, et al. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 2003 ; 424 : 797-801. [CrossRef] [PubMed] [Google Scholar]
- ReileyW, ZhangM, SunSC. Negative regulation of JNK signaling by the tumor suppressor CYLD. J Biol Chem 2004 ; 279 : 55161-55167. [CrossRef] [PubMed] [Google Scholar]
- StegmeierF, SowaME, NalepaG, et al. The tumor suppressor CYLD regulates entry into mitosis. Proc Natl Acad Sci USA 2007 ; 104 : 8869-8874. [CrossRef] [Google Scholar]
- HitomiJ, ChristoffersonDE, NgA, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008 ; 135 : 1311-1323. [CrossRef] [PubMed] [Google Scholar]
- TaurielloDV, HaegebarthA, KuperI, et al. Loss of the tumor suppressor CYLD enhances Wnt/β-catenin signaling through K63-linked ubiquitination of Dvl. Mol Cell 2010 ; 37 : 607-619. [CrossRef] [PubMed] [Google Scholar]
- SunSC. CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes. Cell Death Differ 2010 ; 17 : 25-34. [CrossRef] [PubMed] [Google Scholar]
- PoserI, DomínguezD, de HerrerosAG, et al. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 2001 ; 276 : 24661-24666. [CrossRef] [PubMed] [Google Scholar]
- MassoumiR, KuphalS, HellerbrandC, et al. Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J Exp Med 2009 ; 206 : 221-232. [CrossRef] [PubMed] [Google Scholar]
- AmiriKI, RichmondA. Role of NF-κB in melanoma. Cancer Metastasis Rev 2005 ; 24 : 301-313. [CrossRef] [PubMed] [Google Scholar]
- EspinosaL, CathelinS, D’AltriT, et al. The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. Cancer Cell 2010 ; 18 : 268-281. [CrossRef] [PubMed] [Google Scholar]
- HirschHA, IliopoulosD, JoshiA, et al. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 2010 ; 17 : 348-361. [CrossRef] [PubMed] [Google Scholar]
- IliopoulosD, JaegerSA, HirschHA, et al. STAT3 activation of miR-21 and miR-181b–1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 2010 ; 39 : 493-506. [CrossRef] [PubMed] [Google Scholar]
- AnJ, MoD, LiuH, et al. Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-κB activation. Cancer Cell 2008 ; 14 : 394-407. [CrossRef] [PubMed] [Google Scholar]
- BoehmJS, ZhaoJJ, YaoJ, et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007 ; 129 : 1065-1079. [CrossRef] [PubMed] [Google Scholar]
- HuttiJE, ShenRR, AbbottDW, et al. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKε promotes cell transformation. Mol Cell 2009 ; 34 : 461-472. [CrossRef] [PubMed] [Google Scholar]
- ReileyW, ZhangM, WuX, et al. Regulation of the deubiquitinating enzyme CYLD by IκB kinase γ-dependent phosphorylation. Mol Cell Biol 2005 ; 25 : 3886-3895. [CrossRef] [PubMed] [Google Scholar]
- AnnunziataCM, DavisRE, DemchenkoY, et al. Frequent engagement of the classical and alternative NF-κ pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 2007 ; 12 : 115-130. [CrossRef] [PubMed] [Google Scholar]
- SchmidtA, SchmitzR, GiefingM, et al. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma. Genes Chromosomes Cancer 2010 ; 49 : 803-809. [PubMed] [Google Scholar]
- MassoumiR. Ubiquitin chain cleavage: CYLD at work. Trends Biochem Sci 2010 ; 35 : 392-399. [CrossRef] [PubMed] [Google Scholar]
- HaydenMS, GhoshS. Shared principles in NF-κB signaling. Cell 2008 ; 132 : 344-362. [CrossRef] [PubMed] [Google Scholar]
- GautheronJ, CourtoisG. New functions of NEMO, the regulatory subunit of IKK. Med Sci (Paris) 2008 ; 24 : 954-959. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- KastnerP, ChanS. Notch activation during T-cell leukemogenesis in Ikaros-deficient mice. Med Sci (Paris) 2006 ; 22 : 708-710. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- GrandvauxN. La kinase IKKε : de l’oncogenèse à la résistance au traitement du cancer du sein. Med Sci (Paris) 2011 ; 27 : 619-625. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.